Report: U.S. Asthma/COPD Market

U.S. Asthma/COPD Market

Published by

Frost & Sullivan

Published

2007/10

Content info

149 Pages

Product code

FS57203

Price

From US $ 6000

PDF by E-Mail

Approx. 1-2 business days

Hard Copy/CD-ROM

Approx. 3-4 business days

If you need expedited delivery, please call us.

Abstract

This research service covers the U.S. asthma/COPD market from 2003-2013. Included are a therapeutic overview, patient forecasts, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product class: bronchodilators, anti-inflammatories, and combination therapies. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.